ATLANTA -- Researchers at Dana-Farber Cancer Institute have carried out the largest genomic analysis of patients with smoldering multiple myeloma...
ATLANTA - In a Phase 1 trial, patients with an advanced or aggressive form of systemic mastocytosis (AdvSM), a rare...
ATLANTA - Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following...
ATLANTA - In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of...
ATLANTA - Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after...
Toward the end of life, some leukemia patients depend on blood transfusions to ease their suffering. Unfortunately, the likelihood that...
Credit: Seattle Children's SEATTLE - Dec. 9, 2017 - Results from a phase 2 clinical trial, presented by Seattle Children's...
SAN ANTONIO - Patients with certain advanced hereditary breast cancers may have new treatments options on the horizon, according to...
Intensive surveillance including a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) exam every six months was far more effective in detecting...
SAN ANTONIO -- Younger breast cancer patients who underwent axillary lymph node dissection were more likely to experience arm swelling...
In families who carry certain inherited mutations that increase the risk for melanoma, members who do not carry the mutation...
Credit: Video courtesy of Jefferson Chan, University of Illinois CHAMPAIGN, Ill. -- Areas of hypoxia, or low oxygen in tissue,...
Darmstadt, December 8, 2017. The European Research Council awards an ERC Consolidator Grant to professor Heinz Koeppl and supports him...
Credit: MD Anderson Cancer Center In a randomized, Phase III trial led by researchers at The University of Texas MD...
A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to predict...
SAN ANTONIO - Although digital breast tomosynthesis (DBT), or 3-D mammography, costs more than a digital mammography (DM) screening, it...
Credit: © ESMO LUGANO-GENEVA, Dec. 8, 2017 - A novel compound may restore immune response in patients with melanoma, according...
LUGANO-GENEVA, Dec. 8, 2017 - Researchers have discovered a mechanism of resistance to checkpoint inhibitors and how to reverse it....
Philadelphia, Dec. 8, 2017 -A report in The Journal of Molecular Diagnostics, describes a new simple molecular test to detect...
Credit: Quantum Leap Healthcare Collaborative SAN FRANCISCO, C.A., December 7, 2017 - Quantum Leap Healthcare Collaborative, sponsor and manager of...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.